Cort

Recent Posts

UK payer needs for new device reimbursement

Challenge: A US medical device company wanted to understand how UK payers would view their technology. They engaged Alacrita to find out.
Learn More

Due diligence on a diagnostics investment opportunity

Challenge: A major European venture capital investor needed help to review the business plan and competitive positioning of a novel point-of-care diagnostics company. The company was developing a...
Learn More

Managing preclinical programs into Phase I/II clinical trials

Challenge: A leading cancer research charity needed project management and drug development expertise to shepherd two preclinical programs into Phase I/II clinical trials. Alacrita was engaged to...
Learn More

Fundraising support for an oncology start-up

Challenge: After a seed investment, a startup biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of cytoprotective...
Learn More

Pharmaceutical & Biotech Due Diligence

Alacrita is a leading provider of due diligence to the pharmaceutical industry. Its core team of partners, each of whom has industry experience, are supported by a team of expert, life science...
Learn More